Track the Pharmanutra PR share price and the full insider trade history of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, Pharmanutra PR has logged 5 reports. Market capitalisation: €784.2m. The latest transaction was reported on 16 April 2025 (Other). Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Pharmanutra PR is a company specialized in the health and pharmaceutical sector, listed on the XMIL market. It focuses on the development and commercialization of innovative nutraceutical and pharmaceutical products.